Table 3. Microbiological Characteristics.
| Variable | Enterobacter cloacae-associated PJI (n = 12) | |
|---|---|---|
| Microbial culture | ||
| Monomicrobial | 4 (33.3) | |
| Polymicrobial | 8 (66.7) | |
| Associated bacteria | ||
| Staphylococcus species | 5 (41.7) | |
| Pseudomonas aeruginosa | 4 (33.3) | |
| Enterococcus faecalis | 2 (16.7) | |
| Klebsiella pneumoniae | 2 (16.7) | |
| Other gram-negative bacteria | 2 (16.7) | |
| E. cloacae drug resistance | ||
| Trimethoprim/sulfamethoxazole | 6 (50.0) | |
| Ceftriaxone | 5 (41.7) | |
| Gentamicin | 5 (41.7) | |
| Ceftazidime | 4 (33.3) | |
| Chloramphenicol | 4 (33.3) | |
| Cefuroxime | 3 (25.0) | |
| Amoxicillin | 2 (16.7) | |
| Piperacillin/tazobactam | 2 (16.7) | |
| Cefazolin | 1 (8.3) | |
| Ciprofloxacin | 1 (8.3) | |
| Ertapenem | 1 (8.3) | |
| Imipenem | 1 (8.3) | |
| Meropenem | 1 (8.3) | |
| Tobramycin | 1 (8.3) | |
Values are presented as number (%).
PJI: periprosthetic joint infection.